Главная › Множественная миелома › Огайо › Columbus
Клинические исследования Множественная миелома в городе Columbus, OH
24 исследований по теме Множественная миелома ищут участников в центрах в городе Columbus и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Набор участниковФаза 1/2
- The James Cancer Hospital and Solove Research Institute At Ohio State University, Columbus
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Набор участниковФаза 3
- Ohio State University, Columbus
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Набор участниковФаза 3
- The Ohio State University- James Cancer Hospital, Columbus
- OhioHealth, Columbus
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Набор участниковФаза 2
- Ohio State University Medical Center Dept. of Internal Medicine, Division of Hematology, Columbus
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Набор участниковФаза 1
- Ohio State University Comprehensive Cancer Center, Columbus
Collection of Tissue Samples for Cancer Research
Набор участниковНаблюдательное исследование
- Ohio State University, Columbus
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Набор участниковФаза 2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Набор участниковФаза 3
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- и еще 7
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Набор участниковФаза 1/2
- Ohio State University, Columbus
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Набор участниковФаза 3
- Research Site, Columbus
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Набор участниковФаза 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Набор участниковФаза 1/2
- The Ohio State University /ID# 271336, Columbus
Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
Набор участниковФаза 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Набор участниковФаза 1
- The Ohio State University James Cancer Hospital, Columbus
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Набор участниковФаза 3
- Ohio State Medical Center, James Cancer Center, Columbus
- Ohio Health Research Institute, Columbus
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Набор участниковФаза 2
- The Ohio State University- The James Cancer Hospital and Solove Research Institute, Columbus
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Набор участниковФаза 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma
Набор участников
- Ohio State University Comprehensive Cancer Center, Columbus
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Набор участниковФаза 3
- Study Site 104, Columbus
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Набор участниковФаза 1
- The Ohio State University, Columbus
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Набор участниковФаза 3
- GSK Investigational Site, Columbus
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Набор участниковФаза 1/2
- Ohio State University James Cancer Hospital, Columbus
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Набор участниковФаза 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Набор участниковНаблюдательное исследование
- Ohio State University Medical Center, Columbus
Исследования Множественная миелома в других городах
- New York City, NY60 исследований
- Boston, MA42 исследований
- Atlanta, GA41 исследование
- Houston, TX38 исследований
- Durham, NC37 исследований
- Nashville, TN32 исследований
- Denver, CO26 исследований
- Rochester, MN24 исследований
- Baldwin Park, CA23 исследований
- St. Louis, MO23 исследований
- Washington, DC22 исследований
- Chicago, IL22 исследований
Другие исследования в городе Columbus
- Немелкоклеточный рак легкого55 исследований
- Рак (все виды)39 исследований
- Рак молочной железы39 исследований
- Рак яичников39 исследований
- Рак легких36 исследований
- Острый миелоидный лейкоз34 исследований
- Хронический лимфоцитарный лейкоз29 исследований
- Метастатический рак27 исследований
- Рак эндометрия26 исследований
- Колоректальный рак24 исследований
- Рак простаты24 исследований
- Меланома21 исследование
Источник: ClinicalTrials.gov, данные получены 1 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.